NWF Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.82M Sell
1,977
-89
-4% -$90.2K 0.21% 87
2025
Q4
$2.22M Buy
2,066
+33
+2% +$31.6K 0.25% 73
2025
Q3
$1.55M Buy
2,033
+59
+3% +$43.9K 0.17% 104
2025
Q2
$1.54M Buy
1,974
+1,002
+103% +$779K 0.18% 95
2025
Q1
$803K Buy
972
+129
+15% +$107K 0.11% 125
2024
Q4
$651K Sell
843
-941
-53% -$779K 0.1% 111
2024
Q3
$1.58M Buy
1,784
+301
+20% +$271K 0.23% 80
2024
Q2
$1.34M Buy
1,483
+206
+16% +$165K 0.21% 79
2024
Q1
$994K Buy
1,277
+138
+12% +$98.2K 0.17% 103
2023
Q4
$664K Buy
1,139
+13
+1% +$7.59K 0.13% 125
2023
Q3
$605K Sell
1,126
-2
-0.2% -$1.03K 0.14% 117
2023
Q2
$529K Hold
1,128
0.12% 135
2023
Q1
$529K Buy
+1,128
New +$380K 0.12% 134

Other funds holding LLY

NWF Advisory Services's LLY Position: Q1 2026 in Review

NWF Advisory Services reduced its Eli Lilly (LLY) stake by 4.3% in Q1 2026, selling an estimated $90.2K and leaving 1,977 shares worth $1.82M. The position accounts for 0.21% of the portfolio, ranked #87.

NWF Advisory Services first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.22M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NWF Advisory Services held 1,977 shares of Eli Lilly worth $1.82M as of Q1 2026.
  • NWF Advisory Services sold 89 Eli Lilly shares in Q1 2026, an estimated $90.2K.
  • Eli Lilly made up 0.21% of NWF Advisory Services's portfolio in Q1 2026, its #87 holding.
  • NWF Advisory Services first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • NWF Advisory Services's Eli Lilly position peaked at $2.22M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.